Nuclear Medicine Equipment Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 7.34 Bn

Forecast Year, 2035

USD 10.00 Bn

CAGR, 2026 - 2035

3.14%

Report Coverage

Global

What is Nuclear Medicine Equipment Market Size in 2026?

The global nuclear medicine equipment market size was calculated at USD 7.34 billion in 2025 and is predicted to increase from USD 7.57 billion in 2026 to approximately USD 10.00 billion by 2035, expanding at a CAGR of 3.14% from 2026 to 2035. This market is growing due to the rising prevalence of cancer and cardiovascular diseases, along with increasing demand for advanced diagnostic imaging technologies. Expanding healthcare infrastructure in emerging economies and rising demand for minimally invasive diagnostic procedures also drive the market.

Key Takeaways

• North America dominated the market with a 43% share in 2025.
• Asia Pacific is expected to grow at a CAGR of 5.0% between 2026 and 2035.
• By product, the SPECT systems segment held the biggest market share of 58% in 2025.
• By product, the hybrid PET/SPECT/CT segment is expected to expand at a solid CAGR of 3.9% between 2026 and 2035.
• By application, the oncology segment contributed to the highest market share of 50% in 2025.
• By application, the neurology segment is expected to grow at a robust CAGR of 4.0% between 2026 and 2035.
• By end user, the hospitals segment held a major market share of 60% in 2025.
• By end user, the imaging centers segment is expected to expand at the fastest CAGR of 4.1% from 2026 to 2035.
• By detector technology, the NaI segment held the biggest market share of 70% in 2025.
• By detector technology, the solid state/CZT segment is expected to expand at the fastest CAGR of 4.3% between 2026 and 2035.

Market Overview

The nuclear medicine equipment market refers to the global industry for diagnostic imaging systems that use radioactive tracers to visualize physiological processes inside the body, enhancing disease detection and treatment monitoring. Key technologies include SPECT, PET, hybrid systems (e.g., PET/CT), and planar scintigraphy. These systems are widely used in oncology, cardiology, neurology, and other clinical applications.

The market is expanding because neurological conditions, cardiovascular diseases, and cancer are becoming more common and call for sophisticated diagnostic imaging. Patient outcomes are enhanced by technologies like PET and SPECT systems, which allow for early disease detection and accurate treatment planning. Continuous improvements in imaging systems, increased healthcare spending, and growing awareness of early diagnosis are all contributing to the global market's growth. Additionally, the increasing use of hybrid imaging systems like PET/CT and SPECT/CT is improving the efficiency and accuracy of diagnostics.

How is AI Impacting the Nuclear Medicine Equipment Market?

Artificial intelligence is transforming the nuclear medicine equipment market by improving image reconstruction, lesion detection, and diagnostic accuracy. Clinicians' interpretation time is shortened by AI-powered algorithms that analyze complex imaging data from PET and SPECT systems more rapidly and accurately. AI also facilitates workflow automation, predictive analytics, and dose optimization, which allows for more individualized treatment planning and boosts overall productivity in nuclear medicine departments.

Key Trends in the Nuclear Medicine Equipment Market

• Adoption of Hybrid Imaging Systems: Hybrid imaging systems such as PET/CT and SPECT/CT are increasingly being used to provide more accurate, detailed, and comprehensive diagnostic results by combining functional and anatomical imaging in a single scan.
• Rising Focus on Early Diagnosis: The growing emphasis on early detection of cancer and cardiovascular diseases is significantly increasing the demand for advanced nuclear medicine equipment in hospitals and diagnostic centers.
• Technological Advancements: Continuous improvements in image resolution, faster scanning technologies, and enhanced software capabilities are improving diagnostic accuracy and patient outcomes.
• AI Integration: Artificial intelligence is being integrated into nuclear imaging systems to enhance image analysis, reduce interpretation time, and improve overall workflow efficiency in clinical settings.
• Growth in Personalized Medicine: Nuclear imaging plays a critical role in personalized medicine by enabling targeted therapies and customized treatment plans based on individual patient conditions.
• Expansion of Radiopharmaceutical Use: The development of new radiotracers and radiopharmaceuticals is expanding the clinical applications of nuclear medicine in oncology, cardiology, and neurology.
• Increasing Healthcare Investments: Rising public and private investments in advanced diagnostic infrastructure are supporting the adoption of modern nuclear medicine equipment across healthcare facilities.
• Growing Demand in Emerging Markets: Expanding healthcare access and improving diagnostic capabilities in developing regions are creating new growth opportunities for nuclear medicine equipment manufacturers.

Future Market Outlook

• Expansion in Oncology Applications: The increasing global prevalence of cancer is generating strong demand for advanced nuclear imaging systems that enable accurate tumor detection, staging, and treatment monitoring.
• Development of Novel Radiotracers: Ongoing innovation in radiopharmaceuticals is opening new diagnostic and therapeutic possibilities, thereby creating significant growth opportunities for equipment providers.
• Emerging Market Penetration: Untapped healthcare markets in developing economies present substantial potential for expansion as healthcare infrastructure continues to improve.
• Hybrid Imaging Upgrades: The replacement of outdated standalone systems with advanced hybrid imaging equipment offers steady revenue opportunities for manufacturers.

How is the Nuclear Medicine Equipment Market Strengthening Its Resilience?

Through ongoing technological innovation, diverse radioisotope supply chains, and the expansion of clinical applications beyond oncology into cardiology and neurology, the nuclear medicine equipment market is strengthening its resilience. Dependency on a small number of international suppliers is being lessened by increased government support for domestic radioisotope production and healthcare infrastructure. The market is also staying stable despite supply chain and regulatory issues, thanks to the growing use of AI-driven diagnostics and hybrid imaging systems, which guarantee consistent long-term demand.

Government Initiatives Supporting the Nuclear Medicine Equipment Market

Market Scope

Segment Insights

Product Insights

What made SPECT systems the dominant segment in the nuclear medicine equipment market?

The SPECT systems segment dominated the market with the largest share of 58% in 2025. This is mainly due to the SPECT system's cost-effectiveness, proven clinical efficiency, and widespread availability in hospitals and diagnostic facilities. These systems are a common nuclear medicine diagnostic tool, finding widespread use in cardiac oncology and bone imaging procedures. The segment's dominant position is also reinforced by the robust installed base and steady demand for standard imaging procedures.

The hybrid PET/SPECT/CT segment is expected to grow at a solid CAGR of 3.9% in the coming years because hybrid systems integrate functional and anatomical imaging in a single scan. There is a growing need for accurate and thorough diagnostic imaging. Adoption is speeding up, especially in advanced healthcare settings, due to technological advancements, increased preference for integrated imaging solutions, and improved diagnostic accuracy.

Application Insights

Why did the oncology segment dominate the nuclear medicine equipment market?

The oncology segment dominated the market with a 50% share in 2025 because early detection, staging, and treatment monitoring are becoming increasingly important due to the growing global cancer burden. PET and SPECT scans provide highly accurate visualization of tumors and metastases, enabling early diagnosis and personalized therapy planning. Additionally, the increasing adoption of targeted radiopharmaceuticals and theranostic approaches has driven sustained demand for nuclear medicine equipment in oncology applications.

The neurology segment is expected to grow at the fastest CAGR of 4.0% CAGR in the coming years. This is because of the increasing adoption of advanced imaging technologies, driven by the growing prevalence of neurological conditions like epilepsy, Parkinsons disease, and Alzheimer's disease. Nuclear imaging techniques like PET and SPECT provide detailed insights into brain function, metabolism, and receptor activity, enabling early diagnosis and better treatment planning. Improvements in neuroimaging methods and growing awareness of the importance of early brain disorder diagnosis are also fueling this segment's explosive growth.

End User Insights

Why did the hospital segments dominate the nuclear medicine equipment market?

The hospitals segment dominated the market, accounting for nearly 60% share in 2025. The dominance of the segment is attributed to the availability of advanced imaging infrastructure, skilled professionals, and higher patient inflow. Hospitals typically serve as primary centers for complex diagnostic procedures and integrated treatment services, supporting strong demand for nuclear medicine equipment. Hospitals invest in high-end PET, SPECT, and gamma cameras to support oncology, cardiology, and neurology applications, ensuring comprehensive patient care. Their ability to provide integrated diagnostic and therapeutic services, coupled with government and private funding, drives high adoption of nuclear medicine equipment in this segment.

The imaging centers segment is expected to grow at the fastest CAGR of 4.1% in the coming years due to the increasing demand for specialized, outpatient diagnostic services that are faster and more cost-effective than hospital-based imaging. These centers focus on high-throughput imaging for oncology, cardiology, and neurology, often offering advanced PET and SPECT scans. Rising patient preference for convenient, accessible, and dedicated diagnostic facilities, along with collaborations with hospitals and insurance providers, is driving the adoption of nuclear medicine equipment in imaging centers.

Detector Technology Insights

Why did the NaI segment dominate the nuclear medicine equipment market?

The NaI (sodium iodide) segment dominated the market with the highest share of 70% in 2025, driven by its affordability, dependable performance in traditional nuclear imaging systems, and long history of use in gamma cameras. NaI-based systems are widely installed in healthcare facilities, which further solidifies their dominant position. Image efficiency and clarity have increased due to ongoing advancements in signal processing and crystal design. Furthermore, many diagnostic centers choose NaI detectors because of their reduced maintenance and replacement costs.

The solid state/CZT segment is expected to grow at the fastest CAGR of 4.3% in the coming years. This is because these detectors offer better image resolution, increased sensitivity, and lower radiation exposure compared to traditional technologies. Solid-state detector systems are being adopted at a faster rate due to ongoing technological advancements and the rising demand for high-precision imaging. They are appropriate for next-generation imaging devices due to their compact design and enhanced energy resolution. Innovation in this market is being further fueled by rising R&D expenditures.

Regional Insights

North America Nuclear Medicine Equipment Market Size and Growth 2026 to 2035

The North America nuclear medicine equipment market size is estimated at USD 3.16 billion in 2025 and is projected to reach approximately USD 4.35 billion by 2035, with a 3.25% CAGR from 2026 to 2035.

Why did North America dominate the nuclear medicine equipment market?

North America dominated the nuclear medicine equipment market by capturing a 43% share in 2025, driven by high adoption of cutting-edge imaging systems, robust reimbursement frameworks, and sophisticated healthcare infrastructure. The existence of leading industry participants, significant investments in R&D activities, and the growing demand for early disease detection all contribute to regional expansion. The region's dominant position in the market is also reinforced by favorable regulatory approvals and an increase in the prevalence of chronic diseases.

U.S. Nuclear Medicine Equipment Market Size and Growth 2026 to 2035

The U.S. nuclear medicine equipment market size is calculated at USD 2.37 billion in 2025 and is expected to reach nearly USD 3.30 billion in 2035, accelerating at a strong CAGR of 3.37% between 2026 to 2035.

U.S. Nuclear Medicine Equipment Market Trends

The U.S. dominates the market within North America, bolstered by the rapid adoption of cutting-edge diagnostic technologies and high healthcare spending. Well-established hospital networks, the availability of qualified personnel, and significant investments in nuclear medicine research all contribute to market penetration. Additionally, the country is at the forefront of innovations in healthcare technology, and there is a growing emphasis on precision medicine and AI-integrated imaging systems, which contribute to market growth.

How is the opportunistic rise of Asia Pacific in the market?

Asia Pacific is expected to grow at the fastest CAGR of 5.0% in the coming years because of the growing patient population, the development of healthcare infrastructure, and the increased awareness of early diagnosis. Market development is being stimulated by a rise in foreign direct investments and government initiatives to modernize healthcare systems. Regional market growth is also fueled by increasing access to cutting-edge medical imaging services and the rapid expansion of the medical device manufacturing industry.

India Nuclear Medicine Equipment Market Trends

The market in India is expanding, driven by improving healthcare infrastructure and increasing demand for advanced diagnostic imaging. Government initiatives to enhance public healthcare and the expansion of private hospital chains are boosting equipment adoption. Additionally, rising medical tourism, a large patient population, and growing awareness of early disease detection are sustaining long-term market growth in the country.

Nuclear Medicine Equipment Market Supply Chain Analysis

• R&D

This stage focuses on driving advancements in hybrid imaging systems, detector technologies, and AI-integrated diagnostic solutions. Companies are focusing on improving image resolution, reducing radiation exposure, and enhancing workflow efficiency to strengthen their competitive position.

Key Players: GE HealthCare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems.

• Raw Material Sourcing

This stage involves providing essential components such as detectors, collimators, radiopharmaceuticals, and electronics for nuclear medicine equipment.

Key Players: GE Healthcare, Siemens Healthineers, and Canon Medical Systems.

• Manufacturing & Assembly

Manufacturers assemble nuclear medicine devices like PET, SPECT, and gamma cameras, integrating software, hardware, and safety systems.

Key Players: Philips Healthcare, Siemens Healthineers, and GE Healthcare.

• Distribution to Hospitals, Pharmacies

Nuclear medicine equipment is primarily distributed directly to hospitals and specialized diagnostic centers through established sales networks. Partnerships with radiopharmacies and third-party service providers ensure smooth installation, maintenance, and supply chain management.

Key Players: Curium, Bracco Imaging, Cardinal Health, and Lantheus Holdings.

• Patient Support and Services

Market participants are increasingly offering patient-centric services, including training programs for clinicians and workflow optimization tools for hospitals. Extended service contracts, remote monitoring, and technical support solutions improve equipment uptime and overall patient care quality.

Key Players: United Imaging Healthcare, Spectrum Dynamics Medical, Mediso Medical Imaging Systems, and Digirad Corporation.

Nuclear Medicine Equipment MarketCompanies

• GE HealthCare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Spectrum Dynamics Medical
• Bruker Corporation
• MR Solutions Ltd.
• CUBRESA Inc.
• Digirad Corporation
• DDD-Diagnostics A/S
• Neusoft Medical Systems
• Mediso Ltd.
• Shenzhen Anke High-tech Co., Ltd.
• United Imaging Healthcare
• Positron Corporation

Segments Covered in the Report

By Product/Modality

• SPECT Systems
• PET Systems
• Planar Scintigraphy
• Hybrid PET/SPECT/CT

By Application

• Oncology
• Cardiology
• Neurology
• Others

By End User

• Hospitals
• Imaging Centers
• Academic & Research Institutes
• Others

By Detector Technology

• NaI (Sodium Iodide)
• Solid-State / CZT

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa